Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11673967 Stabilized formulations containing anti-PCSK9 antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Date Filed
July 16, 2020
0
Date of Patent
June 13, 2023
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Application Number
16930595
0
Patent Citations
‌
US Patent 7754208 Binding domain-immunoglobulin fusion proteins
0
‌
US Patent 8062640 High affinity human antibodies to PCSK9
0
‌
US Patent 8080243 Isolated antibody which specifically binds to PCSK9
0
‌
US Patent 8092803 VEGF antagonist formulations for intravitreal administration
0
‌
US Patent 8188233 1B20 PCSK9 antagonists
0
‌
US Patent 7129338 Secretory protein or membrane protein
0
‌
US Patent 7226554 Molding die assembly for rubber members and rubber member produced thereby
0
‌
US Patent 7300754 Methods for detecting the presence of or predisposition to autosomal dominant hypercholesterolemia
0
‌
US Patent 7482147 Ubiquitin protease
0
‌
US Patent 7608693 High affinity human antibodies to human IL-4 receptor
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11673967
0
Patent Primary Examiner
‌
Vanessa L. Ford
0
CPC Code
‌
A61K 2039/505
0
‌
A61M 5/31513
0
‌
A61M 5/3202
0
‌
A61M 5/3287
0
‌
A61M 2202/04
0
‌
C07K 16/40
0
‌
C07K 2317/565
0
‌
C07K 2317/94
0
‌
A61K 39/395
0
‌
A61K 39/3955
0
•••

Find more entities like US Patent 11673967 Stabilized formulations containing anti-PCSK9 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.